 | • レポートコード：MRC2-11QY04501 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、155ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は網膜静脈閉塞症のグローバル市場について調査・分析したレポートです。種類別（分枝網膜動脈閉塞症、網膜中心静脈閉塞症）市場規模、用途別（病院・診療所、研究・学術、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別網膜静脈閉塞症の競争状況、市場シェア ・世界の網膜静脈閉塞症市場：種類別市場規模 2015年-2020年（分枝網膜動脈閉塞症、網膜中心静脈閉塞症） ・世界の網膜静脈閉塞症市場：種類別市場規模予測 2021年-2026年（分枝網膜動脈閉塞症、網膜中心静脈閉塞症） ・世界の網膜静脈閉塞症市場：用途別市場規模 2015年-2020年（病院・診療所、研究・学術、その他） ・世界の網膜静脈閉塞症市場：用途別市場規模予測 2021年-2026年（病院・診療所、研究・学術、その他） ・北米の網膜静脈閉塞症市場分析：米国、カナダ ・ヨーロッパの網膜静脈閉塞症市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの網膜静脈閉塞症市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の網膜静脈閉塞症市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの網膜静脈閉塞症市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Allergan、Bayer、Bristol-Myers Squibb、Regeneron Pharmaceuticals、Ellex Medical Lasers、GlaxoSmithKline Plc.、IRIDEX Corporation、Novartis、Quantel Medical Inc.、Topcon Medical Systems, Inc.、ZEISS、Lumenis、Sanofi Aventis、Bausch Health、Alimera Sciences、Fovea Pharmaceuticals SA、Icon Biosciences、Suzuken Co.Ltd.、Genentech, Inc.、Ranbaxy Pharmaceuticals、Johnson & Johnson Services, Inc.、Teva Pharmaceutical, Pfizer Inc.、Astrazeneca、Aerpio Therapeutics Inc.、Annexin Pharmaceuticals AB ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Retinal vein occlusion (RVO) is a common vascular disorder of the retina and one of the most common causes of vision loss worldwide.
The Americas dominate the global retinal vein occlusion market owing to the increasing prevalence of patients, the presence of major market players, improvement in surgical outcomes, the presence of a strong economic condition, and focus of research institutions on updating technology for new and advanced treatment methods for retinal vein occlusion.
Market Analysis and Insights: Global Retinal Vein Occlusion Market
The global Retinal Vein Occlusion market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Retinal Vein Occlusion Scope and Market Size
Retinal Vein Occlusion market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Retinal Vein Occlusion market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Allergan
Bayer
Bristol-Myers Squibb
Regeneron Pharmaceuticals
Ellex Medical Lasers
GlaxoSmithKline Plc.
IRIDEX Corporation
Novartis
Quantel Medical Inc.
Topcon Medical Systems, Inc.
ZEISS
Lumenis
Sanofi Aventis
Bausch Health
Alimera Sciences
Fovea Pharmaceuticals SA
Icon Biosciences
Suzuken Co.Ltd.
Genentech, Inc.
Ranbaxy Pharmaceuticals
Johnson & Johnson Services, Inc.
Teva Pharmaceutical, Pfizer Inc.
Astrazeneca
Aerpio Therapeutics Inc.
Annexin Pharmaceuticals AB
Market segment by Type, the product can be split into
Branch Retinal Artery Occlusion
Central Retinal Vein Occlusion
Market segment by Application, split into
Hospitals and Clinics
Research and Academics
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Retinal Vein Occlusion Revenue
1.4 Market by Type
1.4.1 Global Retinal Vein Occlusion Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Branch Retinal Artery Occlusion
1.4.3 Central Retinal Vein Occlusion
1.5 Market by Application
1.5.1 Global Retinal Vein Occlusion Market Share by Application: 2020 VS 2026
1.5.2 Hospitals and Clinics
1.5.3 Research and Academics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Retinal Vein Occlusion Market Perspective (2015-2026)
2.2 Global Retinal Vein Occlusion Growth Trends by Regions
2.2.1 Retinal Vein Occlusion Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Retinal Vein Occlusion Historic Market Share by Regions (2015-2020)
2.2.3 Retinal Vein Occlusion Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Retinal Vein Occlusion Market Growth Strategy
2.3.6 Primary Interviews with Key Retinal Vein Occlusion Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Retinal Vein Occlusion Players by Market Size
3.1.1 Global Top Retinal Vein Occlusion Players by Revenue (2015-2020)
3.1.2 Global Retinal Vein Occlusion Revenue Market Share by Players (2015-2020)
3.1.3 Global Retinal Vein Occlusion Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Retinal Vein Occlusion Market Concentration Ratio
3.2.1 Global Retinal Vein Occlusion Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Retinal Vein Occlusion Revenue in 2019
3.3 Retinal Vein Occlusion Key Players Head office and Area Served
3.4 Key Players Retinal Vein Occlusion Product Solution and Service
3.5 Date of Enter into Retinal Vein Occlusion Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Retinal Vein Occlusion Historic Market Size by Type (2015-2020)
4.2 Global Retinal Vein Occlusion Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Retinal Vein Occlusion Market Size by Application (2015-2020)
5.2 Global Retinal Vein Occlusion Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Retinal Vein Occlusion Market Size (2015-2020)
6.2 Retinal Vein Occlusion Key Players in North America (2019-2020)
6.3 North America Retinal Vein Occlusion Market Size by Type (2015-2020)
6.4 North America Retinal Vein Occlusion Market Size by Application (2015-2020)
7 Europe
7.1 Europe Retinal Vein Occlusion Market Size (2015-2020)
7.2 Retinal Vein Occlusion Key Players in Europe (2019-2020)
7.3 Europe Retinal Vein Occlusion Market Size by Type (2015-2020)
7.4 Europe Retinal Vein Occlusion Market Size by Application (2015-2020)
8 China
8.1 China Retinal Vein Occlusion Market Size (2015-2020)
8.2 Retinal Vein Occlusion Key Players in China (2019-2020)
8.3 China Retinal Vein Occlusion Market Size by Type (2015-2020)
8.4 China Retinal Vein Occlusion Market Size by Application (2015-2020)
9 Japan
9.1 Japan Retinal Vein Occlusion Market Size (2015-2020)
9.2 Retinal Vein Occlusion Key Players in Japan (2019-2020)
9.3 Japan Retinal Vein Occlusion Market Size by Type (2015-2020)
9.4 Japan Retinal Vein Occlusion Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Retinal Vein Occlusion Market Size (2015-2020)
10.2 Retinal Vein Occlusion Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Retinal Vein Occlusion Market Size by Type (2015-2020)
10.4 Southeast Asia Retinal Vein Occlusion Market Size by Application (2015-2020)
11 India
11.1 India Retinal Vein Occlusion Market Size (2015-2020)
11.2 Retinal Vein Occlusion Key Players in India (2019-2020)
11.3 India Retinal Vein Occlusion Market Size by Type (2015-2020)
11.4 India Retinal Vein Occlusion Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Retinal Vein Occlusion Market Size (2015-2020)
12.2 Retinal Vein Occlusion Key Players in Central & South America (2019-2020)
12.3 Central & South America Retinal Vein Occlusion Market Size by Type (2015-2020)
12.4 Central & South America Retinal Vein Occlusion Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Allergan
13.1.1 Allergan Company Details
13.1.2 Allergan Business Overview
13.1.3 Allergan Retinal Vein Occlusion Introduction
13.1.4 Allergan Revenue in Retinal Vein Occlusion Business (2015-2020))
13.1.5 Allergan Recent Development
13.2 Bayer
13.2.1 Bayer Company Details
13.2.2 Bayer Business Overview
13.2.3 Bayer Retinal Vein Occlusion Introduction
13.2.4 Bayer Revenue in Retinal Vein Occlusion Business (2015-2020)
13.2.5 Bayer Recent Development
13.3 Bristol-Myers Squibb
13.3.1 Bristol-Myers Squibb Company Details
13.3.2 Bristol-Myers Squibb Business Overview
13.3.3 Bristol-Myers Squibb Retinal Vein Occlusion Introduction
13.3.4 Bristol-Myers Squibb Revenue in Retinal Vein Occlusion Business (2015-2020)
13.3.5 Bristol-Myers Squibb Recent Development
13.4 Regeneron Pharmaceuticals
13.4.1 Regeneron Pharmaceuticals Company Details
13.4.2 Regeneron Pharmaceuticals Business Overview
13.4.3 Regeneron Pharmaceuticals Retinal Vein Occlusion Introduction
13.4.4 Regeneron Pharmaceuticals Revenue in Retinal Vein Occlusion Business (2015-2020)
13.4.5 Regeneron Pharmaceuticals Recent Development
13.5 Ellex Medical Lasers
13.5.1 Ellex Medical Lasers Company Details
13.5.2 Ellex Medical Lasers Business Overview
13.5.3 Ellex Medical Lasers Retinal Vein Occlusion Introduction
13.5.4 Ellex Medical Lasers Revenue in Retinal Vein Occlusion Business (2015-2020)
13.5.5 Ellex Medical Lasers Recent Development
13.6 GlaxoSmithKline Plc.
13.6.1 GlaxoSmithKline Plc. Company Details
13.6.2 GlaxoSmithKline Plc. Business Overview
13.6.3 GlaxoSmithKline Plc. Retinal Vein Occlusion Introduction
13.6.4 GlaxoSmithKline Plc. Revenue in Retinal Vein Occlusion Business (2015-2020)
13.6.5 GlaxoSmithKline Plc. Recent Development
13.7 IRIDEX Corporation
13.7.1 IRIDEX Corporation Company Details
13.7.2 IRIDEX Corporation Business Overview
13.7.3 IRIDEX Corporation Retinal Vein Occlusion Introduction
13.7.4 IRIDEX Corporation Revenue in Retinal Vein Occlusion Business (2015-2020)
13.7.5 IRIDEX Corporation Recent Development
13.8 Novartis
13.8.1 Novartis Company Details
13.8.2 Novartis Business Overview
13.8.3 Novartis Retinal Vein Occlusion Introduction
13.8.4 Novartis Revenue in Retinal Vein Occlusion Business (2015-2020)
13.8.5 Novartis Recent Development
13.9 Quantel Medical Inc.
13.9.1 Quantel Medical Inc. Company Details
13.9.2 Quantel Medical Inc. Business Overview
13.9.3 Quantel Medical Inc. Retinal Vein Occlusion Introduction
13.9.4 Quantel Medical Inc. Revenue in Retinal Vein Occlusion Business (2015-2020)
13.9.5 Quantel Medical Inc. Recent Development
13.10 Topcon Medical Systems, Inc.
13.10.1 Topcon Medical Systems, Inc. Company Details
13.10.2 Topcon Medical Systems, Inc. Business Overview
13.10.3 Topcon Medical Systems, Inc. Retinal Vein Occlusion Introduction
13.10.4 Topcon Medical Systems, Inc. Revenue in Retinal Vein Occlusion Business (2015-2020)
13.10.5 Topcon Medical Systems, Inc. Recent Development
13.11 ZEISS
10.11.1 ZEISS Company Details
10.11.2 ZEISS Business Overview
10.11.3 ZEISS Retinal Vein Occlusion Introduction
10.11.4 ZEISS Revenue in Retinal Vein Occlusion Business (2015-2020)
10.11.5 ZEISS Recent Development
13.12 Lumenis
10.12.1 Lumenis Company Details
10.12.2 Lumenis Business Overview
10.12.3 Lumenis Retinal Vein Occlusion Introduction
10.12.4 Lumenis Revenue in Retinal Vein Occlusion Business (2015-2020)
10.12.5 Lumenis Recent Development
13.13 Sanofi Aventis
10.13.1 Sanofi Aventis Company Details
10.13.2 Sanofi Aventis Business Overview
10.13.3 Sanofi Aventis Retinal Vein Occlusion Introduction
10.13.4 Sanofi Aventis Revenue in Retinal Vein Occlusion Business (2015-2020)
10.13.5 Sanofi Aventis Recent Development
13.14 Bausch Health
10.14.1 Bausch Health Company Details
10.14.2 Bausch Health Business Overview
10.14.3 Bausch Health Retinal Vein Occlusion Introduction
10.14.4 Bausch Health Revenue in Retinal Vein Occlusion Business (2015-2020)
10.14.5 Bausch Health Recent Development
13.15 Alimera Sciences
10.15.1 Alimera Sciences Company Details
10.15.2 Alimera Sciences Business Overview
10.15.3 Alimera Sciences Retinal Vein Occlusion Introduction
10.15.4 Alimera Sciences Revenue in Retinal Vein Occlusion Business (2015-2020)
10.15.5 Alimera Sciences Recent Development
13.16 Fovea Pharmaceuticals SA
10.16.1 Fovea Pharmaceuticals SA Company Details
10.16.2 Fovea Pharmaceuticals SA Business Overview
10.16.3 Fovea Pharmaceuticals SA Retinal Vein Occlusion Introduction
10.16.4 Fovea Pharmaceuticals SA Revenue in Retinal Vein Occlusion Business (2015-2020)
10.16.5 Fovea Pharmaceuticals SA Recent Development
13.17 Icon Biosciences
10.17.1 Icon Biosciences Company Details
10.17.2 Icon Biosciences Business Overview
10.17.3 Icon Biosciences Retinal Vein Occlusion Introduction
10.17.4 Icon Biosciences Revenue in Retinal Vein Occlusion Business (2015-2020)
10.17.5 Icon Biosciences Recent Development
13.18 Suzuken Co.Ltd.
10.18.1 Suzuken Co.Ltd. Company Details
10.18.2 Suzuken Co.Ltd. Business Overview
10.18.3 Suzuken Co.Ltd. Retinal Vein Occlusion Introduction
10.18.4 Suzuken Co.Ltd. Revenue in Retinal Vein Occlusion Business (2015-2020)
10.18.5 Suzuken Co.Ltd. Recent Development
13.19 Genentech, Inc.
10.19.1 Genentech, Inc. Company Details
10.19.2 Genentech, Inc. Business Overview
10.19.3 Genentech, Inc. Retinal Vein Occlusion Introduction
10.19.4 Genentech, Inc. Revenue in Retinal Vein Occlusion Business (2015-2020)
10.19.5 Genentech, Inc. Recent Development
13.20 Ranbaxy Pharmaceuticals
10.20.1 Ranbaxy Pharmaceuticals Company Details
10.20.2 Ranbaxy Pharmaceuticals Business Overview
10.20.3 Ranbaxy Pharmaceuticals Retinal Vein Occlusion Introduction
10.20.4 Ranbaxy Pharmaceuticals Revenue in Retinal Vein Occlusion Business (2015-2020)
10.20.5 Ranbaxy Pharmaceuticals Recent Development
13.21 Johnson & Johnson Services, Inc.
10.21.1 Johnson & Johnson Services, Inc. Company Details
10.21.2 Johnson & Johnson Services, Inc. Business Overview
10.21.3 Johnson & Johnson Services, Inc. Retinal Vein Occlusion Introduction
10.21.4 Johnson & Johnson Services, Inc. Revenue in Retinal Vein Occlusion Business (2015-2020)
10.21.5 Johnson & Johnson Services, Inc. Recent Development
13.22 Teva Pharmaceutical, Pfizer Inc.
10.22.1 Teva Pharmaceutical, Pfizer Inc. Company Details
10.22.2 Teva Pharmaceutical, Pfizer Inc. Business Overview
10.22.3 Teva Pharmaceutical, Pfizer Inc. Retinal Vein Occlusion Introduction
10.22.4 Teva Pharmaceutical, Pfizer Inc. Revenue in Retinal Vein Occlusion Business (2015-2020)
10.22.5 Teva Pharmaceutical, Pfizer Inc. Recent Development
13.23 Astrazeneca
10.23.1 Astrazeneca Company Details
10.23.2 Astrazeneca Business Overview
10.23.3 Astrazeneca Retinal Vein Occlusion Introduction
10.23.4 Astrazeneca Revenue in Retinal Vein Occlusion Business (2015-2020)
10.23.5 Astrazeneca Recent Development
13.24 Aerpio Therapeutics Inc.
10.24.1 Aerpio Therapeutics Inc. Company Details
10.24.2 Aerpio Therapeutics Inc. Business Overview
10.24.3 Aerpio Therapeutics Inc. Retinal Vein Occlusion Introduction
10.24.4 Aerpio Therapeutics Inc. Revenue in Retinal Vein Occlusion Business (2015-2020)
10.24.5 Aerpio Therapeutics Inc. Recent Development
13.25 Annexin Pharmaceuticals AB
10.25.1 Annexin Pharmaceuticals AB Company Details
10.25.2 Annexin Pharmaceuticals AB Business Overview
10.25.3 Annexin Pharmaceuticals AB Retinal Vein Occlusion Introduction
10.25.4 Annexin Pharmaceuticals AB Revenue in Retinal Vein Occlusion Business (2015-2020)
10.25.5 Annexin Pharmaceuticals AB Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Retinal Vein Occlusion Key Market Segments
Table 2. Key Players Covered: Ranking by Retinal Vein Occlusion Revenue
Table 3. Ranking of Global Top Retinal Vein Occlusion Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Retinal Vein Occlusion Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Branch Retinal Artery Occlusion
Table 6. Key Players of Central Retinal Vein Occlusion
Table 7. Global Retinal Vein Occlusion Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Retinal Vein Occlusion Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Retinal Vein Occlusion Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Retinal Vein Occlusion Market Share by Regions (2015-2020)
Table 11. Global Retinal Vein Occlusion Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Retinal Vein Occlusion Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Retinal Vein Occlusion Market Growth Strategy
Table 17. Main Points Interviewed from Key Retinal Vein Occlusion Players
Table 18. Global Retinal Vein Occlusion Revenue by Players (2015-2020) (Million US$)
Table 19. Global Retinal Vein Occlusion Market Share by Players (2015-2020)
Table 20. Global Top Retinal Vein Occlusion Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Vein Occlusion as of 2019)
Table 21. Global Retinal Vein Occlusion by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Retinal Vein Occlusion Product Solution and Service
Table 24. Date of Enter into Retinal Vein Occlusion Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Retinal Vein Occlusion Market Size by Type (2015-2020) (Million US$)
Table 27. Global Retinal Vein Occlusion Market Size Share by Type (2015-2020)
Table 28. Global Retinal Vein Occlusion Revenue Market Share by Type (2021-2026)
Table 29. Global Retinal Vein Occlusion Market Size Share by Application (2015-2020)
Table 30. Global Retinal Vein Occlusion Market Size by Application (2015-2020) (Million US$)
Table 31. Global Retinal Vein Occlusion Market Size Share by Application (2021-2026)
Table 32. North America Key Players Retinal Vein Occlusion Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Retinal Vein Occlusion Market Share (2019-2020)
Table 34. North America Retinal Vein Occlusion Market Size by Type (2015-2020) (Million US$)
Table 35. North America Retinal Vein Occlusion Market Share by Type (2015-2020)
Table 36. North America Retinal Vein Occlusion Market Size by Application (2015-2020) (Million US$)
Table 37. North America Retinal Vein Occlusion Market Share by Application (2015-2020)
Table 38. Europe Key Players Retinal Vein Occlusion Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Retinal Vein Occlusion Market Share (2019-2020)
Table 40. Europe Retinal Vein Occlusion Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Retinal Vein Occlusion Market Share by Type (2015-2020)
Table 42. Europe Retinal Vein Occlusion Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Retinal Vein Occlusion Market Share by Application (2015-2020)
Table 44. China Key Players Retinal Vein Occlusion Revenue (2019-2020) (Million US$)
Table 45. China Key Players Retinal Vein Occlusion Market Share (2019-2020)
Table 46. China Retinal Vein Occlusion Market Size by Type (2015-2020) (Million US$)
Table 47. China Retinal Vein Occlusion Market Share by Type (2015-2020)
Table 48. China Retinal Vein Occlusion Market Size by Application (2015-2020) (Million US$)
Table 49. China Retinal Vein Occlusion Market Share by Application (2015-2020)
Table 50. Japan Key Players Retinal Vein Occlusion Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Retinal Vein Occlusion Market Share (2019-2020)
Table 52. Japan Retinal Vein Occlusion Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Retinal Vein Occlusion Market Share by Type (2015-2020)
Table 54. Japan Retinal Vein Occlusion Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Retinal Vein Occlusion Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Retinal Vein Occlusion Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Retinal Vein Occlusion Market Share (2019-2020)
Table 58. Southeast Asia Retinal Vein Occlusion Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Retinal Vein Occlusion Market Share by Type (2015-2020)
Table 60. Southeast Asia Retinal Vein Occlusion Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Retinal Vein Occlusion Market Share by Application (2015-2020)
Table 62. India Key Players Retinal Vein Occlusion Revenue (2019-2020) (Million US$)
Table 63. India Key Players Retinal Vein Occlusion Market Share (2019-2020)
Table 64. India Retinal Vein Occlusion Market Size by Type (2015-2020) (Million US$)
Table 65. India Retinal Vein Occlusion Market Share by Type (2015-2020)
Table 66. India Retinal Vein Occlusion Market Size by Application (2015-2020) (Million US$)
Table 67. India Retinal Vein Occlusion Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Retinal Vein Occlusion Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Retinal Vein Occlusion Market Share (2019-2020)
Table 70. Central & South America Retinal Vein Occlusion Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Retinal Vein Occlusion Market Share by Type (2015-2020)
Table 72. Central & South America Retinal Vein Occlusion Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Retinal Vein Occlusion Market Share by Application (2015-2020)
Table 74. Allergan Company Details
Table 75. Allergan Business Overview
Table 76. Allergan Product
Table 77. Allergan Revenue in Retinal Vein Occlusion Business (2015-2020) (Million US$)
Table 78. Allergan Recent Development
Table 79. Bayer Company Details
Table 80. Bayer Business Overview
Table 81. Bayer Product
Table 82. Bayer Revenue in Retinal Vein Occlusion Business (2015-2020) (Million US$)
Table 83. Bayer Recent Development
Table 84. Bristol-Myers Squibb Company Details
Table 85. Bristol-Myers Squibb Business Overview
Table 86. Bristol-Myers Squibb Product
Table 87. Bristol-Myers Squibb Revenue in Retinal Vein Occlusion Business (2015-2020) (Million US$)
Table 88. Bristol-Myers Squibb Recent Development
Table 89. Regeneron Pharmaceuticals Company Details
Table 90. Regeneron Pharmaceuticals Business Overview
Table 91. Regeneron Pharmaceuticals Product
Table 92. Regeneron Pharmaceuticals Revenue in Retinal Vein Occlusion Business (2015-2020) (Million US$)
Table 93. Regeneron Pharmaceuticals Recent Development
Table 94. Ellex Medical Lasers Company Details
Table 95. Ellex Medical Lasers Business Overview
Table 96. Ellex Medical Lasers Product
Table 97. Ellex Medical Lasers Revenue in Retinal Vein Occlusion Business (2015-2020) (Million US$)
Table 98. Ellex Medical Lasers Recent Development
Table 99. GlaxoSmithKline Plc. Company Details
Table 100. GlaxoSmithKline Plc. Business Overview
Table 101. GlaxoSmithKline Plc. Product
Table 102. GlaxoSmithKline Plc. Revenue in Retinal Vein Occlusion Business (2015-2020) (Million US$)
Table 103. GlaxoSmithKline Plc. Recent Development
Table 104. IRIDEX Corporation Company Details
Table 105. IRIDEX Corporation Business Overview
Table 106. IRIDEX Corporation Product
Table 107. IRIDEX Corporation Revenue in Retinal Vein Occlusion Business (2015-2020) (Million US$)
Table 108. IRIDEX Corporation Recent Development
Table 109. Novartis Business Overview
Table 110. Novartis Product
Table 111. Novartis Company Details
Table 112. Novartis Revenue in Retinal Vein Occlusion Business (2015-2020) (Million US$)
Table 113. Novartis Recent Development
Table 114. Quantel Medical Inc. Company Details
Table 115. Quantel Medical Inc. Business Overview
Table 116. Quantel Medical Inc. Product
Table 117. Quantel Medical Inc. Revenue in Retinal Vein Occlusion Business (2015-2020) (Million US$)
Table 118. Quantel Medical Inc. Recent Development
Table 119. Topcon Medical Systems, Inc. Company Details
Table 120. Topcon Medical Systems, Inc. Business Overview
Table 121. Topcon Medical Systems, Inc. Product
Table 122. Topcon Medical Systems, Inc. Revenue in Retinal Vein Occlusion Business (2015-2020) (Million US$)
Table 123. Topcon Medical Systems, Inc. Recent Development
Table 124. ZEISS Company Details
Table 125. ZEISS Business Overview
Table 126. ZEISS Product
Table 127. ZEISS Revenue in Retinal Vein Occlusion Business (2015-2020) (Million US$)
Table 128. ZEISS Recent Development
Table 129. Lumenis Company Details
Table 130. Lumenis Business Overview
Table 131. Lumenis Product
Table 132. Lumenis Revenue in Retinal Vein Occlusion Business (2015-2020) (Million US$)
Table 133. Lumenis Recent Development
Table 134. Sanofi Aventis Company Details
Table 135. Sanofi Aventis Business Overview
Table 136. Sanofi Aventis Product
Table 137. Sanofi Aventis Revenue in Retinal Vein Occlusion Business (2015-2020) (Million US$)
Table 138. Sanofi Aventis Recent Development
Table 139. Bausch Health Company Details
Table 140. Bausch Health Business Overview
Table 141. Bausch Health Product
Table 142. Bausch Health Revenue in Retinal Vein Occlusion Business (2015-2020) (Million US$)
Table 143. Bausch Health Recent Development
Table 144. Alimera Sciences Company Details
Table 145. Alimera Sciences Business Overview
Table 146. Alimera Sciences Product
Table 147. Alimera Sciences Revenue in Retinal Vein Occlusion Business (2015-2020) (Million US$)
Table 148. Alimera Sciences Recent Development
Table 149. Fovea Pharmaceuticals SA Company Details
Table 150. Fovea Pharmaceuticals SA Business Overview
Table 151. Fovea Pharmaceuticals SA Product
Table 152. Fovea Pharmaceuticals SA Revenue in Retinal Vein Occlusion Business (2015-2020) (Million US$)
Table 153. Fovea Pharmaceuticals SA Recent Development
Table 154. Icon Biosciences Company Details
Table 155. Icon Biosciences Business Overview
Table 156. Icon Biosciences Product
Table 157. Icon Biosciences Revenue in Retinal Vein Occlusion Business (2015-2020) (Million US$)
Table 158. Icon Biosciences Recent Development
Table 159. Suzuken Co.Ltd. Company Details
Table 160. Suzuken Co.Ltd. Business Overview
Table 161. Suzuken Co.Ltd. Product
Table 162. Suzuken Co.Ltd. Revenue in Retinal Vein Occlusion Business (2015-2020) (Million US$)
Table 163. Suzuken Co.Ltd. Recent Development
Table 164. Genentech, Inc. Company Details
Table 165. Genentech, Inc. Business Overview
Table 166. Genentech, Inc. Product
Table 167. Genentech, Inc. Revenue in Retinal Vein Occlusion Business (2015-2020) (Million US$)
Table 168. Genentech, Inc. Recent Development
Table 169. Ranbaxy Pharmaceuticals Company Details
Table 170. Ranbaxy Pharmaceuticals Business Overview
Table 171. Ranbaxy Pharmaceuticals Product
Table 172. Ranbaxy Pharmaceuticals Revenue in Retinal Vein Occlusion Business (2015-2020) (Million US$)
Table 173. Ranbaxy Pharmaceuticals Recent Development
Table 174. Johnson & Johnson Services, Inc. Company Details
Table 175. Johnson & Johnson Services, Inc. Business Overview
Table 176. Johnson & Johnson Services, Inc. Product
Table 177. Johnson & Johnson Services, Inc. Revenue in Retinal Vein Occlusion Business (2015-2020) (Million US$)
Table 178. Johnson & Johnson Services, Inc. Recent Development
Table 179. Teva Pharmaceutical, Pfizer Inc. Company Details
Table 180. Teva Pharmaceutical, Pfizer Inc. Business Overview
Table 181. Teva Pharmaceutical, Pfizer Inc. Product
Table 182. Teva Pharmaceutical, Pfizer Inc. Revenue in Retinal Vein Occlusion Business (2015-2020) (Million US$)
Table 183. Teva Pharmaceutical, Pfizer Inc. Recent Development
Table 184. Astrazeneca Company Details
Table 185. Astrazeneca Business Overview
Table 186. Astrazeneca Product
Table 187. Astrazeneca Revenue in Retinal Vein Occlusion Business (2015-2020) (Million US$)
Table 188. Astrazeneca Recent Development
Table 189. Aerpio Therapeutics Inc. Company Details
Table 190. Aerpio Therapeutics Inc. Business Overview
Table 191. Aerpio Therapeutics Inc. Product
Table 192. Aerpio Therapeutics Inc. Revenue in Retinal Vein Occlusion Business (2015-2020) (Million US$)
Table 193. Aerpio Therapeutics Inc. Recent Development
Table 194. Annexin Pharmaceuticals AB Company Details
Table 195. Annexin Pharmaceuticals AB Business Overview
Table 196. Annexin Pharmaceuticals AB Product
Table 197. Annexin Pharmaceuticals AB Revenue in Retinal Vein Occlusion Business (2015-2020) (Million US$)
Table 198. Annexin Pharmaceuticals AB Recent Development
Table 199. Research Programs/Design for This Report
Table 200. Key Data Information from Secondary Sources
Table 201. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Retinal Vein Occlusion Market Share by Type: 2020 VS 2026
Figure 2. Branch Retinal Artery Occlusion Features
Figure 3. Central Retinal Vein Occlusion Features
Figure 4. Global Retinal Vein Occlusion Market Share by Application: 2020 VS 2026
Figure 5. Hospitals and Clinics Case Studies
Figure 6. Research and Academics Case Studies
Figure 7. Others Case Studies
Figure 8. Retinal Vein Occlusion Report Years Considered
Figure 9. Global Retinal Vein Occlusion Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Retinal Vein Occlusion Market Share by Regions: 2020 VS 2026
Figure 11. Global Retinal Vein Occlusion Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Retinal Vein Occlusion Market Share by Players in 2019
Figure 14. Global Top Retinal Vein Occlusion Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Vein Occlusion as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Retinal Vein Occlusion Revenue in 2019
Figure 16. North America Retinal Vein Occlusion Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Retinal Vein Occlusion Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Retinal Vein Occlusion Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Retinal Vein Occlusion Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Retinal Vein Occlusion Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Retinal Vein Occlusion Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Retinal Vein Occlusion Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
網膜静脈閉塞症治療薬の世界市場（～2026年） Retinal vein occlusion (RVO) is a sight-threatening retinal vascular disorder associated with macular edema and neovascularization. The RVO is mainly of two types based on the anatomy of the vein occlusion. The two types are branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CR…- バルーン閉塞装置の世界市場（～2026年） Balloon-occlusion devices cease flow in the ICA during the period of angioplasty and stenting.This device consists of a hypotube with a balloon on the end. After placement of the occlusion balloon distal to the carotid lesion, the lumen of the hypotube is used to inflate the balloon. Market Analysis…
- 網膜剥離の世界市場（～2026年） Retinal detachment occurs when the light-sensitive membrane (retina) in the back of the eye separates from its supporting layers. Most of the retinal detachments occurs due to retinal break, tear or hole. Retinal detachment can cause partial or total blindness, depending upon how much of the retina …
- 深部静脈血栓症（DVT）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Deep Vein Thrombosis (DVT) Drug Market The global Deep Vein Thrombosis (DVT) Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Deep Vein Thrombosis (DVT) Drug Scope and Market Si…
- 静脈瘤治療の世界市場（～2026年） Varicose Veins also referred to as varicosities are swollen, blue, twisted veins that appear on the skin. These are often seen near the legs. Market Analysis and Insights: Global Varicose Vein Treatment Market The global Varicose Vein Treatment market size is projected to reach US$ 401.9 million by …